Evidence map›Paper›PMID 38238453›Full record

ArticleBone marrow transplantation2024

The impact of social vulnerability index on survival following autologous stem cell transplant for multiple myeloma.

Kiarash Salafian, Christine Mazimba, Leonid Volodin, Indumathy Varadarajan, Asal Pilehvari, Wen You, Ziyad O Knio, Karen Ballen

Abstract read
In one paragraph

Article in Bone marrow transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Social vulnerability, access to care, and outcomes in hemophilia.Blood vessels, thrombosis & hemostasis · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Access to Transplant Care and Social Determinants of Health.Advances in experimental medicine and biology · 2025
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kiarash Salafian *Department of Medicine, University of Virginia Health, Charlottesville, VA, USA.ORCID 0000-0002-5311-0815
Christine Mazimba *Division of Hematology/Oncology, University of Virginia Health, Charlottesville, VA, USA.
Leonid VolodinDivision of Hematology/Oncology, University of Virginia Health, Charlottesville, VA, USA.
Indumathy VaradarajanDivision of Hematology/Oncology, University of Virginia Health, Charlottesville, VA, USA.
Asal PilehvariDepartment of Public Health Sciences, University of Virginia, and University of Virginia Comprehensive Cancer Center, Charlottesville, VA, USA.
Wen YouDepartment of Public Health Sciences, University of Virginia, and University of Virginia Comprehensive Cancer Center, Charlottesville, VA, USA.
Ziyad O KnioDepartment of Anesthesiology, University of Virginia Health, Charlottesville, VA, USA.ORCID 0000-0001-5696-873X
Karen BallenDivision of Hematology/Oncology, University of Virginia Health, Charlottesville, VA, USA. KB3TC@virginia.edu.ORCID 0000-0003-1706-3975

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autologous hematopoietic stem cell transplantation (ASCT) is the standard of care for eligible patients with multiple myeloma (MM) to prolong progression-free survival (PFS). While several factors affect survival following ASCT, the impact of social determinants of health such as the CDC Social Vulnerability Index (SVI) is not well documented. This single-center retrospective analysis evaluated the impact of SVI on PFS following ASCT in MM patients. 225 patients with MM who underwent ASCT participated, with 51% transplanted in the last 5 years. At 5 years post-transplant, 55 (50%) achieved PFS and 66 (60%) remained alive. Higher SVI values were significantly associated with lower odds of PFS (OR = 0.521, p < 0.01, 95% CI [0.41, 0.66]) and OS (OR = 0.592, p < 0.01, 95% CI [0.46, 0.76]) post-transplant. Greater vulnerability scores in the socioeconomic status (OR = 0.890; 95% CI: [0.82, 0.96]), household characteristics (OR = 0.912; 95% CI: [0.87, 0.95]), and racial and ethnic minority status (OR = 0.854; 95% CI: [0.81, 0.90]) themes significantly worsened the odds of PFS. These results suggest high SVI areas may need more resources to achieve optimal PFS and OS. Future studies will focus on addressing factors within the socioeconomic status, household characteristics, and racial and ethnic minority subthemes, as these have a more pronounced effect on PFS.

Indexed as

Hematopoietic Stem Cell TransplantationMultiple MyelomaDisease-Free SurvivalEthnicityHumansMinority GroupsRetrospective StudiesSocial VulnerabilityStem Cell TransplantationTransplantation, AutologousTreatment Outcome

Identifiers

PMID38238453
PMCPMC10994832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.